J. Safra Sarasin Holding Ag Madrigal Pharmaceuticals, Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.79 Trillion
- Q2 2025
A detailed history of J. Safra Sarasin Holding Ag transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 6,823 shares of MDGL stock, worth $2.45 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
6,823
Previous 1,792
280.75%
Holding current value
$2.45 Million
Previous $594 Million
247.88%
% of portfolio
0.04%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding MDGL
# of Institutions
363Shares Held
23.5MCall Options Held
955KPut Options Held
419K-
Janus Henderson Group PLC London, X02.21MShares$792 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$754 Million39.89% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$726 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$716 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$709 Million7.8% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $6.14B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...